Journal of Endocrinological Investigation

, Volume 6, Issue 6, pp 435–440 | Cite as

Adenohypophyseal hormone levels in the cerebrospinal fluid of patients with pituitary disease

  • L. Dogliotti
  • R. Faggiuolo
  • F. Orlandi
  • P. Paccotti
  • A. Angeli


Measurement of adenohypophyseal hormones in the cerebrospinal fluid (CSF) was recently proposed as an useful procedure to differentiate pituitary intra and extrasellar tumors. So far, data reported are conflicting. We measured the concentrations of GH, TSH, FSH, LH and PRL in CSF and plasma in 30 controls and in 37 patients with various pituitary diseases (18 intrasellar adenomas, 14 extrasellar adenomas and 5 empty sella syndromes). The concentrations of exam-ined hormones in CSF were very low or undetectable in all control subjects. In most patients with pituitary tumors, adenohypophyseal hormones were found to be present in CSF, in great amounts. No significant differences were found between intra and extrasellar tumors. In agreement with recently reported data, no significant correlation was found between GH, TSH, FSH and LH levels in CSF and plasma, while a significant correlation (p<0.01) was obtained between CSF and plasma levels of PRL, either in all patients or in those with extrasellar tumors only. All patients bearing an empty sella had PRL detectable in CSF: in 2 cases PRL levels were very high. In conclusion our data do not confirm that measurement of adenohypophyseal hormones in CSF represents an useful screening to differentiate tumors with extrasellar extension. PRL data deserve interest in order to gain understanding of the hormone dynamics between CSF and vascular compartments.


Pituitary hormones CSF pituitary tumors empty sella 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Linfoot J.A., Garcia J.F., Wei W., Fink R., Sarin R., Born J.L., Lawrence J.H. Human growth hormone levels in cerebrospinal fluid. J. Clin. Endocrinol. Metab. 31: 230, 1970.PubMedCrossRefGoogle Scholar
  2. 2.
    Kleerekoper M., Donald R.A., Posen S. Corticotrophin in cerebrospinal fluid of patients with Nelson’s syndrome. Lancet 7: 74, 1972.CrossRefGoogle Scholar
  3. 3.
    Allen J.P., Kendall J.W., McGilvra R, Lamorena T.L., Castro A. Adrenocorticotropic and growth hormone secretion: studies during pneumoencephalography. Arch. Neurol. 37:325, 1974.CrossRefGoogle Scholar
  4. 4.
    Schroeder L.L., Johnson J.D., Malarkey W.B. Cerebrospinal fluid prolactin: a reflection of abnormal prolactin secretion in patients with pituitary tumors. J. Clin. Endocrinol. Metab. 43:1255, 1976.PubMedCrossRefGoogle Scholar
  5. 5.
    Jordan R.M., Kendall J.W., Seaich J.L, Allen J.P., Paulsen C.A., Kerber C.W., Vanderlaan W.P. Cerebrospinal fluid hormone concentration in the eva luation of pituitary tumors. Ann. Intern. Med. 85: 49, 1976.PubMedCrossRefGoogle Scholar
  6. 6.
    Hanson E.J. Jr., Miller R.H., Randall R.V. Suprasellar extension of tumor associated with in-creased cerebrospinal fluid activity of growth hormone. Mayo Clinic. Proc. 57: 412, 1976.Google Scholar
  7. 7.
    Schaub C., Blue-Pajot M.T., Szikla G., Lornet C., Talairach J. Distribution of growth hormone and thyroid-stimulating hormone in cerebrospinal fluid and pathological compartments of the central nervous system. J. Neurol. Sci. 13: 123, 1977.CrossRefGoogle Scholar
  8. 8.
    Assies J., Schellekens A.P.M., Touber J.L. Prolactin in human cerebrospinal fluid. J. Clin. Endocrinol. Metab. 46: 576, 1978.PubMedCrossRefGoogle Scholar
  9. 9.
    Jordan R.M., McDonald S.D., Stevens E.A., Kendall J.W. Cerebral spinal fluid prolactin: a re-evaluation. Arch. Int. Med. 739:208, 1979.CrossRefGoogle Scholar
  10. 10.
    Turpin G., Heshmati H.M., Roger M., Cesselin F., Lagoguey M., Baulieu J.L., De Gennes J.L. Le dosage de stimulines hypophysaires dans le liquide céphalorachidien chez le sujet normal et en pathologie hypothalamo-hypophysaire. Annales Endocrinol. 41: 21, 1980.Google Scholar
  11. 11.
    Post K.D., Biller B.J., Jackson I.M.D. Pituitary hormone conentrations in cerebrospinal fluid in patients with pituitary tumors. In: Post K.D., Jackson I.M.D., Reichlin S. (Eds.), The Pituitary adenoma. Plenum Medical Book Co., New York, 1980, p. 239.CrossRefGoogle Scholar
  12. 12.
    Braunstein G.D., Hassen G., Kamdar V., Nelson J.C. Anterior pituitary hormone levels in the cerebrospinal fluid of patients with pituitary and parasejlar tumors. Fertil. Steril. 36:164, 1981.PubMedGoogle Scholar
  13. 13.
    Faglia G., Beck-Peccoz P., Ferrari C, Ambrosi B., Spada A., Travaglini P., Paracchi S. Plasma thyrotropin response to thyrotropin-releasing hormone in patients with pituitary and hypothalamic disorders. J. Clin. Endocrinol. Metab. 37: 595, 1973.PubMedCrossRefGoogle Scholar
  14. 14.
    Faglia G., Bitensky L., Pinchera A., Ferrari C., Paracchi A., Beck-Peccoz P., Ambrosi B., Spada A. Thyrotropin secretion in patients with central hypothy roidism: evidence for reduced biological activity of immunoreactive thyrotropin. J. Clin. Endocrinol. Metab. 48: 989, 1979.PubMedCrossRefGoogle Scholar
  15. 15.
    Luboshitzky R., Barzilai D. Suprasellar extension of tumor associated with increased cerebrospinal fluid activity of LH and FSH. Acta Endocrinol. (Kbh.) 87: 673, 1978.Google Scholar
  16. 16.
    Perria C., Barreca T., Magnani G., Sannia A., Rolandi E. Prolactin in serum and cerebrospinal fluid in patients with pituitary adenomas. IRCS Med. Sciences 8 366, 1980.Google Scholar
  17. 17.
    Jimerson D.C., Post R.M., Skyler J., Bunney W.E. Prolactin in cerebrospinal fluid and dopamine function in man. J. Pharmacol. 28:845, 1976.CrossRefGoogle Scholar
  18. 18.
    Wode-Helgodt B., Eneroth P., Fyro B., Gullberg B., Sedvall G. Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients. Acta Psychiatr. Scand. 56: 280, 1977.PubMedCrossRefGoogle Scholar
  19. 19.
    Jordan R.M., Kendall J.W., Kerber C.W. The primary empty sella syndrome. Am. J. Med. 62:569, 1977.PubMedCrossRefGoogle Scholar
  20. 20.
    Clemens J.A., Sawyer B.D. Identification of prolactin in cerebrospinal fluid. Exp. Brain Res. 27: 399, 1974.Google Scholar
  21. 21.
    Horvath E., Kovacs K. Misplaced exocytosis. Arch. Pathol. 97:221, 1974.PubMedGoogle Scholar
  22. 22.
    Annunziato L. Regulatory mechanisms of tuberohypophyseal dopaminergic neurons. In: McLeod R.M., Scapagnini U. (Eds.), Central and peripheral regulation of prolactin function. Raven Press, New York, 1980, p. 59.Google Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1983

Authors and Affiliations

  • L. Dogliotti
    • 1
  • R. Faggiuolo
    • 1
  • F. Orlandi
    • 1
  • P. Paccotti
    • 1
  • A. Angeli
    • 1
  1. 1.Patologia Medica DUniversità degli Studi di TorinoTorinoItaly

Personalised recommendations